Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atorvastatin and simvastatin are both statin medications, but there is no approved combination product containing both atorvastatin and simvastatin together in a single pill. Each drug is used to lower cholesterol by inhibiting the enzyme HMG-CoA reductase in the liver, thereby reducing the production of cholesterol. Statins are prescribed to reduce LDL ('bad') cholesterol, decrease triglycerides, modestly increase HDL ('good') cholesterol, and lower the risk of cardiovascular events such as heart attack and stroke[1][5][6]. Atorvastatin (Lipitor) and simvastatin (Zocor) are typically prescribed individually or in combination with other drugs (e.g., ezetimibe for Vytorin), but not together as a dual statin combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on atorvastatin + simvastatin.